Palomino Laboratories (PALX) Operating Expenses (2023 - 2025)

Palomino Laboratories has disclosed Operating Expenses across 3 years of filings, most recently posting -$1.9 million for Q4 2025.

• In Q4 2025, Operating Expenses fell 1499.08% year-over-year to -$1.9 million; the TTM figure through Dec 2025 stood at $30000.0 (down 86.5% YoY), while the FY2025 annual figure was $30000.0, down 78.58% from the prior year.
• Operating Expenses came in at -$1.9 million for Q4 2025 at Palomino Laboratories, down from $1.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.6 million in Q3 2025 to a low of -$1.9 million in Q4 2025.
• Average Operating Expenses over 3 years is $32772.8, with a median of $37718.5 recorded in 2023.
• The largest YoY upside for Operating Expenses was 129958.51% in 2025 against a maximum downside of 1499.08% in 2025.
• Over 3 years, Operating Expenses stood at $32574.0 in 2023, then jumped by 323.53% to $137962.0 in 2024, then plunged by 1499.08% to -$1.9 million in 2025.
• Per Business Quant data, the three most recent Operating Expenses figures were -$1.9 million in Q4 2025, $1.6 million in Q3 2025, and $337445.0 in Q2 2025.